HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephen M Taylor Selected Research

Factor Va

8/2015The Role of C5a Receptor Signaling in Endotoxin-Induced Miscarriage and Preterm Birth.
8/2005Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.
1/2004Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm.
4/2002Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephen M Taylor Research Topics

Disease

11Inflammation (Inflammations)
02/2016 - 01/2004
11Reperfusion Injury
06/2013 - 04/2002
7Wounds and Injuries (Trauma)
01/2019 - 04/2002
6Ischemia
02/2016 - 04/2002
5Neutropenia
08/2006 - 04/2002
5Edema (Dropsy)
08/2005 - 04/2002
4Spinal Cord Injuries (Spinal Cord Injury)
01/2019 - 06/2012
4Necrosis
03/2011 - 11/2002
3Neural Tube Defects (Exencephaly)
03/2016 - 04/2013
3Stroke (Strokes)
06/2012 - 08/2010
3Fibrosis (Cirrhosis)
11/2011 - 02/2002
3Body Weight (Weight, Body)
06/2006 - 05/2005
3Colitis
08/2005 - 11/2003
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2005 - 11/2003
2Melanoma (Melanoma, Malignant)
10/2019 - 01/2016
2Carcinogenesis
10/2019 - 01/2016
2Premature Birth (Birth, Premature)
08/2015 - 01/2013
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
09/2013 - 12/2008
2Pre-Eclampsia (Preeclampsia)
04/2013 - 01/2013
2Sepsis (Septicemia)
03/2013 - 08/2006
2Neurodegenerative Diseases (Neurodegenerative Disease)
06/2012 - 04/2010
2Hypertension (High Blood Pressure)
11/2011 - 06/2006
2Arthritis (Polyarthritis)
03/2011 - 09/2002
2Infections
06/2010 - 01/2008
2Neuroinflammatory Diseases
04/2010 - 07/2009
2Hemorrhagic Shock
08/2006 - 01/2004
2Shock
08/2006 - 01/2004
2Hypotension (Low Blood Pressure)
09/2003 - 11/2002
1Neoplasms (Cancer)
10/2019
1Congenital Abnormalities (Deformity)
03/2016
1Spontaneous Abortion (Miscarriage)
08/2015
1Gliosis
04/2015
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
04/2013
1Folic Acid Deficiency (Folic Acid Deficiencies)
04/2013
1Habitual Abortion (Recurrent Miscarriage)
01/2013
1Pneumonia (Pneumonitis)
11/2012
1Acute Lung Injury
11/2012
1Traumatic Brain Injuries (Traumatic Brain Injury)
06/2012
1Atherosclerotic Plaque (Atheroma)
07/2011
1Atherosclerosis
07/2011
1Rheumatoid Arthritis
03/2011
1Ischemic Stroke
08/2010
1Alzheimer Disease (Alzheimer's Disease)
04/2010
1Dementia (Dementias)
04/2010

Drug/Important Bio-Agent (IBA)

20Complement System Proteins (Complement)IBA
08/2015 - 04/2002
13Anaphylatoxin C5a ReceptorIBA
10/2019 - 04/2002
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2010 - 04/2002
6AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA
01/2006 - 04/2002
5Complement C5a (Complement 5a)IBA
10/2019 - 01/2004
5Peroxidase (Myeloperoxidase)IBA
05/2005 - 01/2003
4Proteins (Proteins, Gene)FDA Link
03/2016 - 01/2004
4Factor VaIBA
08/2015 - 04/2002
4CollagenIBA
11/2011 - 02/2002
4Secretory Phospholipases A2IBA
03/2011 - 09/2003
4hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA
04/2010 - 08/2005
4Cyclic PeptidesIBA
01/2006 - 04/2002
3Folic Acid (Vitamin M)FDA LinkGeneric
03/2016 - 04/2013
3EnzymesIBA
03/2011 - 05/2005
3Sulfonic AcidsIBA
08/2005 - 11/2003
3Pharmaceutical PreparationsIBA
08/2005 - 11/2003
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2003 - 04/2002
2CytokinesIBA
10/2019 - 01/2004
2LigandsIBA
10/2019 - 02/2016
2Messenger RNA (mRNA)IBA
10/2019 - 01/2004
2Complement Receptors (Complement Receptor)IBA
01/2019 - 04/2015
2EphrinsIBA
02/2016 - 11/2012
2SaltsIBA
11/2011 - 02/2002
2Desoxycorticosterone Acetate (DOCA)FDA Link
11/2011 - 02/2002
2Group II Phospholipases A2IBA
03/2011 - 05/2005
2Infliximab (Remicade)FDA Link
03/2011 - 11/2003
2Prednisolone (Predate)FDA LinkGeneric
03/2011 - 11/2003
2AntigensIBA
03/2011 - 09/2002
2AcidsIBA
06/2006 - 05/2005
2CreatinineIBA
01/2004 - 01/2003
2pirfenidoneIBA
11/2002 - 02/2002
1ChemokinesIBA
10/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
1TensinsIBA
01/2019
1CXC ChemokinesIBA
01/2019
1AutoantibodiesIBA
03/2016
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
02/2016
1complement C3a receptorIBA
01/2016
1LipopolysaccharidesIBA
08/2015
1EndotoxinsIBA
08/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2013
1Peptides (Polypeptides)IBA
04/2013
1HMGB1 Protein (HMG1)IBA
03/2013
1Ephrin-A1 (Ephrin A1)IBA
11/2012
1Oxygen (Dioxygen)IBA
09/2012
1Glucose (Dextrose)FDA LinkGeneric
09/2012
1Apolipoproteins E (ApoE)IBA
07/2011
1Leflunomide (Arava)FDA LinkGeneric
03/2011
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2011
1Therapeutic UsesIBA
01/2011
1AdiponectinIBA
08/2010
1Adiponectin ReceptorsIBA
08/2010
1Amyloid beta-PeptidesIBA
04/2010

Therapy/Procedure

6Therapeutics
10/2019 - 07/2009
3Drug Therapy (Chemotherapy)
01/2011 - 05/2004